Radiodermatitis Market

Radiodermatitis Market Size, Share, Growth Analysis, By Product(Topical, Corticosteroids), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy) - Industry Forecast 2024-2031

Report ID: SQMIG35G2240 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 72 | Figures: 66

Radiodermatitis Market News

  • On May 4, 2023, Albert Einstein College of Medicine, U.S explained a simple antibacterial treatment solves a severe skin problem caused by radiation therapy, Staphylococcus aureus (SA), often shortened to "staph", usually lives harmlessly on the skin, often in the nose and armpits. But they can cause infections if the skin of the incision breaks. Radiation weakens the skin structure at the treatment site and can cause infection, allowing SA to penetrate the outer layer of the skin.
  • In January 2021, Integra Lifesciences Holdings Inc. acquired ACell Inc. and its proprietary MatriStem UBMTM technology to further enhance its complex wound management solutions.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Radiodermatitis Market size was valued at USD 517.44 Million in 2021 and is poised to grow from USD 539.17 million in 2022 to USD 749.32 million by 2030, growing at a CAGR of 4.2% during the forecast period (2023-2030).

The reports highlight significant developments in the radiodermatitis market, encompassing both organic and inorganic growth strategies. Companies in the radiodermatitis market are employing organic growth strategies such as product launches, approvals, patents, and events to expand their presence during the forecast period. In parallel, inorganic growth strategies such as acquisitions, partnerships, and collaborations have facilitated business expansion and increased customer base. Radiodermatitis market players are expected to find lucrative growth opportunities in the market due to the rising demand. Below is a list of companies actively involved in the radiodermatitis market. '3M COMPANY', 'BAUSCH HEALTH COMPANIES INC', 'BAYER AG', 'BMG PHARMA SPA', 'CONVATEC GROUP PLC', 'GLAXOSMITHKLINE PLC', 'HELSINN HEALTHCARE SA', 'MOLNLYCKE HEALTH CARE', 'MYLAN N.V.', 'SMITH & NEPHEW PLC', 'STRATPHARMA AG'

The increasing adoption of radiation therapy for cancer treatment contributes to the higher incidence of radiodermatitis cases. As radiation therapy becomes more widely used, the demand for radiodermatitis treatments also increases

Increasing Adoption of Advanced Treatment Options: The market is witnessing a growing adoption of advanced treatment options for radiodermatitis. Topical products, dressings, and other innovative therapies are gaining popularity due to their effectiveness in managing radiation-induced skin damage.

In 2022, Asia Pacific dominated the market, accounting for 46.0% of the total market share. This significant share can be attributed to the increasing number of cancer patients in the region, driving the demand for radiodermatitis treatments. Moreover, key businesses in the region have engaged in substantial collaborations to expand their product range, further bolstering their market presence. Renowned pharmaceutical firms in the region actively promote their products, contributing to higher end-user adoption rates. Favorable government initiatives that support research activities and the increasing outsourcing by industrialized economies also act as key growth drivers for the Asia Pacific market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Smart Exoskeleton Market
Buy Now GET FREE SAMPLE
Veterinary Reference Laboratory Market
Buy Now GET FREE SAMPLE
Artificial Intelligence in MRI Market
Buy Now GET FREE SAMPLE
Immunoglobulin Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Radiodermatitis Market

Product ID: SQMIG35G2240

$5,300
BUY NOW GET FREE SAMPLE